NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.

NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction. Biol Blood Marrow Transplant. 2010 May; 16(5):565-86.

View in: PubMed

subject areas

Antigen Presentation
B-Lymphocytes
Education
Graft vs Leukemia Effect
Hematologic Neoplasms
Hematopoietic Stem Cell Transplantation
Humans
Killer Cells, Natural
National Cancer Institute (U.S.)
Secondary Prevention
T-Lymphocytes
Transplantation, Homologous
United States

authors with profiles

Michael R. Bishop